CoCensys Inc.: The Irvine biopharmaceutical company reported...
- Share via
CoCensys Inc.: The Irvine biopharmaceutical company reported a net loss of $6.1 million, or 27 cents a share, for the first quarter, compared with a net loss of $5.6 million, or 26 cents a share, for the comparable period last year. Revenue increased 13% to $1.8 million from $1.6 million.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
